Company intelligence / Profile preview

Affirma Biotech

Barcelona, Barcelona, Spainaffirmabio.com ↗

Ownership: Private
Development stage: Other

Overview

Affirma Biotech has discovered a new family of orally administered drug candidates that stimulate the immune system to fight a wide range of viral and severe infections. These compounds are currently being optimized in preclinical studies. The company recently closed a seed round to advance proof-of-concept work but has not yet reported clinical results.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Small moleculeImmunomodulator
Industry: Biotech

Partnerships

Early-stage collaborations with business associations, universities, startup incubators in Barcelona & Catalonia region

Beyond the preview

Go deeper on Affirma Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Affirma Biotech.

Explore the full profile